George Yancopoulos, EVP, CSO, & President Regn Res Labs at REGENERON PHARMACEUTICALS INC (REGN), sold 400 shares at $25.01 ($10K) on 2007-04-16, disclosed to the SEC on 2007-04-17.
Scheduled sale ($10k) by EVP, CSO, & President Regn Res Labs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.97 | 300 | $7K | 75.0% |
| 2 | $25.00 | 78 | $2K | 19.5% |
| 3 | $25.01 | 22 | $550 | 5.5% |
| Total | $24.98 avg | 400 | $10K | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |